ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
0.005
0.00
( 0.00% )
Actualizado: 18:00:00

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
0.005
Postura de Compra
0.005
Postura de Venta
0.01
Volume Operado de la Acción
7,000
0.005 Rango del Día 0.005
0.005 Rango de 52 semanas 0.04
Capitalización de Mercado [m]
Precio Anterior
0.005
Precio de Apertura
0.005
Última hora de negociación
08:42:42
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
30,522
Acciones en circulación
132,634,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
0.00
Beneficio por acción (BPA)
-0.02
turnover
254k
Beneficio neto
-2.97M

Acerca de Aequus Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Vancouver, British Columbia, Can
Fundado
-
Aequus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker AQS. The last closing price for Aequus Pharmaceuticals was $0.01. Over the last year, Aequus Pharmaceuticals shares have traded in a share price range of $ 0.005 to $ 0.04.

Aequus Pharmaceuticals currently has 132,634,000 shares in issue. The market capitalisation of Aequus Pharmaceuticals is $663,170 . Aequus Pharmaceuticals has a price to earnings ratio (PE ratio) of 0.00.

AQS Últimas noticias

Aequus Reports Second Quarter 2023 Financial Highlights and General Update

VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus...

Aequus Announces Zimed PF Now Available in Canada

VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a specialty pharmaceutical company announced...

Aequus Announces Zimed PF Website Launch

VANCOUVER, British Columbia, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a specialty pharmaceutical company, are...

Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada

VANCOUVER, British Columbia, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a specialty pharmaceutical company announces...

Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)

VANCOUVER, British Columbia, July 06, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announces today it has increased its debt by...

Aequus Provides General Update and First Quarter 2023 Financial Highlights

VANCOUVER, British Columbia, May 30, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus...

Aequus Provides General Update and Fiscal 2022 Financial Results

VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on...

Aequus Grants Stock Options

VANCOUVER, British Columbia, April 19, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announces that it has granted incentive stock...

Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%) and Board Update

VANCOUVER, British Columbia, April 05, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announced today it has entered into a loan...

Aequus Announces Health Canada Notice of Compliance (NOC) for Zimed® Preservative Free (Bimatoprost 0.03%)

VANCOUVER, British Columbia, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), is pleased to announce that Health Canada has...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1000.0050.0050.005237850.005CS
4000.0050.0050.00547830.005CS
12-0.01-66.66666666670.0150.0150.005305220.0093098CS
26-0.015-750.020.040.005545030.01782768CS
52-0.02-800.0250.040.005813570.02037057CS
156-0.1-95.23809523810.1050.120.005661170.03413049CS
260-0.125-96.15384615380.130.290.0051153950.12263197CS

AQS - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Aequus Pharmaceuticals?
El precio actual de las acciones de Aequus Pharmaceuticals es $ 0.005
¿Cuántas acciones de Aequus Pharmaceuticals están en circulación?
Aequus Pharmaceuticals tiene 132,634,000 acciones en circulación
¿Cuál es la capitalización de mercado de Aequus Pharmaceuticals?
La capitalización de mercado de Aequus Pharmaceuticals es CAD 663.17k
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Aequus Pharmaceuticals?
Aequus Pharmaceuticals ha negociado en un rango de $ 0.005 a $ 0.04 durante el último año
¿Cuál es el ratio de efectivo a ventas de Aequus Pharmaceuticals?
El ratio de efectivo a ventas de Aequus Pharmaceuticals es 0
¿Cuál es la moneda de reporte de Aequus Pharmaceuticals?
Aequus Pharmaceuticals presenta sus resultados financieros en CAD
¿Cuál es el último ingresos anual de Aequus Pharmaceuticals?
El último ingresos anual de Aequus Pharmaceuticals es CAD 254k
¿Cuál es el último beneficio anual de Aequus Pharmaceuticals?
El último beneficio anual de Aequus Pharmaceuticals es CAD -2.97M
¿Cuál es la dirección registrada de Aequus Pharmaceuticals?
La dirección registrada de Aequus Pharmaceuticals es SUITE 2600, 595 BURRARD STREET, VANCOUVER, BRITISH COLUMBIA, V7X 1L3
¿Cuál es la dirección del sitio web de Aequus Pharmaceuticals?
La dirección del sitio web de Aequus Pharmaceuticals es www.aequuspharma.ca
¿En qué sector industrial opera Aequus Pharmaceuticals?
Aequus Pharmaceuticals opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
IMPC.PImpact Acquisitions Corp
$ 0.18
(157.14%)
2k
SCLTSearchlight Resources Inc
$ 0.01
(100.00%)
11k
IDIdentillect Technologies Corp
$ 0.01
(100.00%)
1,000
TVITVI Pacific Inc
$ 0.01
(100.00%)
1,000
MAHMarksmen Energy Inc
$ 0.01
(100.00%)
4.8k
ADG.HArcus Development Group Inc
$ 0.005
(-66.67%)
149k
ETUE2gold Inc
$ 0.005
(-50.00%)
305.3k
GNFIGenifi Inc
$ 0.005
(-50.00%)
3.9k
ENTGEntourage Health Corp
$ 0.005
(-50.00%)
740.02k
DMIDiamcor Mining Inc
$ 0.015
(-40.00%)
1.31M
QNCQuantum Emotion Corp
$ 1.50
(27.12%)
6.86M
GPUSAlset AI Ventures Inc
$ 0.15
(-6.25%)
3.51M
ONE01 Communique Laboratory Inc
$ 0.65
(38.30%)
3.16M
MURMurchison Minerals Ltd
$ 0.015
(0.00%)
1.57M
MATEBlockmate Ventures Inc
$ 0.295
(7.27%)
1.33M
brooklyn13 brooklyn13 1 minuto hace
But it’s karma, no? You support the shooting of the CEO and the attack on the woman in Perth as justified, as karma. In your own words

So why isn’t this the same thing? Oh, I forgot that you’re the master of situational ethics, it’s karma only when you like the outcome
Mojocash Mojocash 1 minuto hace
There is no need for an R/S. The structure is great at 461 mill unrestricted o/s and in the event they did dilute in the future, you do see the authorized is 2.5 billion. They have a long way to go before a r/s. It's all silly talk fear mongering. If they ever did do an r/s, it would be to move to
HLLK
researcher59 researcher59 1 minuto hace
IDR has gotten beat up lately and tax loss selling is adding to the downward pressure. Those option premiums are decent. I put it on my watchlist, thanks.
powerbattles powerbattles 2 minutos hace
$2.91 Breakout $3.00 next station $5.00
WIMI
sweet crude sweet crude 2 minutos hace
ELEK .03 quantum data centers

https://x.com/nextrealm_ai/status/1873787961768370324
ELEK
georgie18 georgie18 2 minutos hace
Not in...I have too many other solid plays...🥳
Penny Stocks 2.0 Penny Stocks 2.0 2 minutos hace
$HLLK .0055 NASDAQ'S $PERI PARTNER is HUGE $405,000,000 MARKET CAP 
HLLK PERI
blackhawks blackhawks 2 minutos hace
If you don't have the curiosity to investigate the meaning of algorithms, been in the vernacular for decades, then AI is going to remain a frightening mystery to you.

Perhaps this guy can reassure you? He at lest is aware of both the opportunities and challenges AI poses.
vlispxpert vlispxpert 2 minutos hace
KAVL took profits
KAVL
Penny Stocks 2.0 Penny Stocks 2.0 2 minutos hace
$HLLK .0055 NASDAQ'S $PERI PARTNER is HUGE $405,000,000 MARKET CAP 
HLLK PERI
Hussar Squared Hussar Squared 3 minutos hace
$NBRI North Bay Resources 1.5 ton gold ore bags at the Bishop Mill, California
https://x.com/northbayres/status/1873788945542324303?s=46
NBRI
fnyack fnyack 3 minutos hace
It looks like everyday is a buying opportunity with XRP, but I'm holding out for $0.50. Guys pay attention the Cabal is skimming all of the cream ffom the top, join them and take little profits when you can. Happy New Year to all.
XRPUSD
vlispxpert vlispxpert 3 minutos hace
AMPX took profits
AMPX
No-Quarter No-Quarter 3 minutos hace
January will present some challenges...

https://home.treasury.gov/news/press-releases/jy2763

https://www.foxnews.com/politics/trump-accuses-former-speaker-kevin-mccarthy-one-dumbest-political-decisions-made-years

"In June 2023, the Fiscal Responsibility A
peteypickem peteypickem 3 minutos hace
BURU .93
BURU
koolmc koolmc 3 minutos hace
yep nice trade opps here
CYFRF
AugustaFriends AugustaFriends 3 minutos hace
$FFIE a must see weekly chart -- you make up your mind if to get in or not -- BEAUTY of a weekly chart. Below


Chart >>> https://stockcharts.com/h-sc/ui?s=FFIE&p=W&yr=0&mn=6&dy=0&id=p20389108903
FFIE
powerbattles powerbattles 3 minutos hace
$2.13 Hod Super Monster $$$
NXU
Stock_Barber Stock_Barber 4 minutos hace
I figured that out long ago and added him to ignore.

There are several characters here that appear to be performers playing a role!

I'm not sure we should be surprised as DBMM is a social marketing company...

Would you be surprised if you found out that
DBMM
dstock07734 dstock07734 4 minutos hace
FeMike,

I am really curious if Nascent's technologies could be complementary to DCVax-L. How do you think?

https://www.nascentbiotech.com/products/

https://investorshub.advfn.com/uimage/uploads/2024/12/30/akkuuDC_Combinations.jpg
NWBO
mankind mankind 4 minutos hace
When the Sh^&t hits the fan like when Gamestop went parabolic 2021, Both Schwab and IB held up well. Robinhood was criminal, not sure if webull was adequate. I would never give webull or these other no-names a large % of your investment dollars.
ddls ddls 4 minutos hace
No ones buying those fumes anymore.🤠
BIEL
Moonboy1 Moonboy1 4 minutos hace
This one is very disappointing. Seems like a slow bleed until reverse split? Isn't news due due of the form 74 letter any day?
TNXP
tw0122 tw0122 4 minutos hace
.93
SMX
Penny Stocks 2.0 Penny Stocks 2.0 4 minutos hace
GTSM working hard to keep us below .0055 they know what's coming.
HLLK

Su Consulta Reciente

Delayed Upgrade Clock